quant Healthcare Fund Regular Growth
EquitySector - HealthcareVery High Risk
Regular
NAV (22-May-26)
Returns (Since Inception)
Fund Overview
Fund Size
₹352 Cr
Expense Ratio
2.47%
ISIN
INF966L01CG3
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
18 Jul 2023
About this fund
As of 22-May-26, it has a Net Asset Value (NAV) of ₹16.17, Assets Under Management (AUM) of 351.89 Crores, and an expense ratio of 2.47%.
- quant Healthcare Fund Regular Growth has given a CAGR return of 18.39% since inception.
- The fund's asset allocation comprises around 88.96% in equities, 0.00% in debts, and 11.04% in cash & cash equivalents.
- You can start investing in quant Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.
Performance against Category Average
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+5.29%
+12.08% (Cat Avg.)
Since Inception
+18.39%
— (Cat Avg.)
Portfolio Summaryas of 30th April 2026
| Equity | ₹313.03 Cr | 88.96% |
| Others | ₹38.86 Cr | 11.04% |
Top Holdings
All Holdings
Equity
Debt & Others
| Name | Type  | Amount | Holdings |
|---|---|---|---|
| Zydus Wellness Ltd | Equity | ₹32.64 Cr | 9.27% |
| Anthem Biosciences Ltd | Equity | ₹32.25 Cr | 9.17% |
| Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹31.31 Cr | 8.90% |
| SMS Pharmaceuticals Ltd | Equity | ₹31.2 Cr | 8.86% |
| Viyash Scientific Ltd | Equity | ₹30.32 Cr | 8.62% |
| Treps 04-May-2026 Depo 10 | Cash - Repurchase Agreement | ₹26.4 Cr | 7.50% |
| Alivus Life Sciences Ltd | Equity | ₹25.57 Cr | 7.27% |
| HFCL Ltd | Equity | ₹25.14 Cr | 7.14% |
| Pfizer Ltd | Equity | ₹22.59 Cr | 6.42% |
| Aurobindo Pharma Ltd | Equity | ₹18.11 Cr | 5.15% |
| ICICI Prudential Life Insurance Co Ltd | Equity | ₹15.29 Cr | 4.35% |
| HDFC Life Insurance Co Ltd | Equity | ₹13.36 Cr | 3.80% |
| Medplus Health Services Ltd | Equity | ₹13.09 Cr | 3.72% |
| Nca-Net Current Assets | Cash | ₹-8.43 Cr | 2.40% |
| GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹7.59 Cr | 2.16% |
| Tbill | Bond - Gov't/Treasury | ₹5.98 Cr | 1.70% |
| Gland Pharma Ltd | Equity | ₹4.92 Cr | 1.40% |
| Icici Bank Limited 26/05/2026 | Equity - Future | ₹4.71 Cr | 1.34% |
| Hdfc Life Insurance Co Ltd 26/05/2026 | Equity - Future | ₹3.89 Cr | 1.11% |
| Tbill | Bond - Gov't/Treasury | ₹3 Cr | 0.85% |
| Tbill | Bond - Gov't/Treasury | ₹2.99 Cr | 0.85% |
| India (Republic of) | Bond - Short-term Government Bills | ₹2.99 Cr | 0.85% |
| Day Tbill | Bond - Gov't/Treasury | ₹2.97 Cr | 0.84% |
| India (Republic of) | Bond - Short-term Government Bills | ₹2.96 Cr | 0.84% |
| Strides Pharma Science Ltd | Equity | ₹1.05 Cr | 0.30% |
Allocation By Market Cap (Equity)
Large Cap Stocks
3.80%
Mid Cap Stocks
20.81%
Small Cap Stocks
61.90%
Allocation By Credit Quality (Debt)
AAA
Other Allocation
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Healthcare | ₹217.99 Cr | 61.95% |
| Consumer Defensive | ₹32.64 Cr | 9.27% |
| Financial Services | ₹28.66 Cr | 8.14% |
| Technology | ₹25.14 Cr | 7.14% |
Risk & Performance Ratios
Standard Deviation
This fund
--
Cat. avg.
16.62%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.99
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.77
Higher the better
Fund Managers
Sanjeev Sharma
Since July 2023
Ankit A. Pande
Since July 2023
Sandeep Tandon
Since July 2023
Varun Pattani
Since January 2025
Sameer Kate
Since March 2025
Ayusha Kumbhat
Since February 2025
Yug Tibrewal
Since March 2025
Additional Scheme Detailsas of 30th April 2026
ISIN INF966L01CG3 | Expense Ratio 2.47% | Exit Load 1.00% | Fund Size ₹352 Cr | Age 2 years 10 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty Healthcare TR INR |
Investment Objective
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Tax Treatment
Capital Gains Taxation:
Dividend Taxation:
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Similar Sector - Healthcare Funds
About the AMC
Quant Mutual Fund
Total AUM
₹82,406 Cr
Address
A.M. Road, Prabhadevi, Mumbai, 400025
Other Funds by Quant Mutual Fund
| Fund name | Expense Ratio | Exit Load | Fund size | 1Y  |
|---|---|---|---|---|
| qsif Sector Rotation Long-Short Fund Direct Growth Very High Risk | - | 1.0% | - | - |
| qsif Active Asset Allocator Long-Short Fund Regular Growth Very High Risk | - | 1.0% | - | - |
| qsif Equity Ex-Top 100 Long-Short Fund Direct Growth Very High Risk | - | 1.0% | ₹211.68 Cr | - |
| qsif Hybrid Long-Short Fund Direct Growth Very High Risk | - | 0.0% | ₹149.08 Cr | - |
| qsif Equity Long-Short Fund Direct Growth Very High Risk | - | 1.0% | ₹574.25 Cr | - |
| quant Equity Savings Fund Direct Growth Moderately High risk | 1.1% | 1.0% | ₹46.37 Cr | - |
| Quant Arbitrage Fund Direct Growth Low Risk | 1.4% | 0.0% | ₹351.30 Cr | 7.4% |
| Quant PSU Fund Direct Growth Very High Risk | 1.9% | 1.0% | ₹501.75 Cr | 6.6% |
| Quant Consumption Fund Direct Growth Very High Risk | 2.3% | 1.0% | ₹189.75 Cr | -7.4% |
| Quant Commodities Fund Direct Growth Very High Risk | 1.2% | 1.0% | ₹340.27 Cr | 14.9% |
| Quant Momentum Fund Direct Growth Very High Risk | 1.4% | 1.0% | ₹1318.91 Cr | 6.3% |
| Quant Teck Fund Direct Growth Very High Risk | 1.5% | 1.0% | ₹235.47 Cr | -15.4% |
| Quant Value Fund Direct Growth Very High Risk | 1.2% | 1.0% | ₹1756.45 Cr | 16.5% |
| Quant BFSI Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹753.02 Cr | 22.0% |
| quant Healthcare Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹351.89 Cr | 7.0% |
| Quant Quantamental Fund Direct Growth Very High Risk | 4.4% | 1.0% | ₹1569.13 Cr | 12.5% |
| Tata Quant Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹61.70 Cr | 8.5% |
| Quant Focused fund Direct Growth Very High Risk | 1.8% | 1.0% | ₹813.02 Cr | 7.1% |
| Quant Large and Mid Cap Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹3249.46 Cr | 7.4% |
| Quant Active Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹7466.00 Cr | 3.4% |
| Quant Small Cap Fund Direct Growth Very High Risk | 1.1% | 1.0% | ₹30373.69 Cr | 6.4% |
| Quant Absolute Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹2024.48 Cr | 11.3% |
| Quant Infrastructure Fund Direct Growth Very High Risk | 1.1% | 0.0% | ₹3072.93 Cr | 9.1% |
| Quant Multi Asset Fund Direct Growth High Risk | 1.3% | 1.0% | ₹5257.41 Cr | 21.6% |
| Quant Flexi Cap Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹6593.52 Cr | 9.6% |
| Quant Tax Plan Direct Growth Very High Risk | 0.8% | 0.0% | ₹12505.69 Cr | 11.2% |
| Quant Liquid Plan Direct Growth Low to Moderate Risk | 0.3% | 0.0% | ₹1266.31 Cr | 6.0% |
| Quant Mid Cap Fund Direct Growth Very High Risk | 1.8% | 0.0% | ₹7904.71 Cr | 2.2% |
| Quant Gilt Fund Direct Growth Moderate Risk | 0.5% | 0.0% | ₹83.20 Cr | 0.1% |
| Quant Manufacturing Fund Direct Growth Very High Risk | 1.0% | 1.0% | ₹669.33 Cr | 8.7% |
| Quant Business Cycle Fund Direct Growth Very High Risk | 1.9% | 1.0% | ₹964.68 Cr | 3.1% |
| Quant ESG Equity Fund Direct Growth Very High Risk | 1.1% | 1.0% | ₹264.40 Cr | 12.3% |
| Quant Overnight Fund Direct Growth Low Risk | 0.2% | 0.0% | ₹63.65 Cr | 5.2% |
| Quant Large Cap Fund Direct Growth Very High Risk | 1.1% | 1.0% | ₹3112.32 Cr | 6.2% |
| Quant Dynamic Asset Allocation Fund Direct Growth Very High Risk | 1.0% | 1.0% | ₹901.32 Cr | 2.2% |
Risk Level
Your principal amount will be at Very High Risk
Take control of your wealth
Related Articles
Still got questions?
We're here to help.
What is the current NAV of quant Healthcare Fund Regular Growth?
What is the portfolio composition of quant Healthcare Fund Regular Growth?
Who manages the quant Healthcare Fund Regular Growth?
- Sanjeev Sharma
- Ankit A. Pande
- Sandeep Tandon
- Varun Pattani
- Sameer Kate
- Ayusha Kumbhat
- Yug Tibrewal
Track & Analyse all your investments in one place
Compare your portfolio's performance with benchmarks
Identify potential risks in your portfolio and learn to fix them
Track all your family's investments in one place
Trending Mutual Funds Searches
Popular Equity Funds
Popular Debt Funds
Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.
Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.
